Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1991 1
1994 2
1996 4
1998 1
1999 1
2000 2
2001 4
2002 4
2003 2
2004 2
2006 1
2007 2
2009 2
2010 3
2011 2
2013 2
2014 1
2015 2
2016 1
2017 3
2018 4
2019 1
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Nongenital herpes simplex virus.
Usatine RP, Tinitigan R. Usatine RP, et al. Am Fam Physician. 2010 Nov 1;82(9):1075-82. Am Fam Physician. 2010. PMID: 21121552 Free article.
Recurrences of herpes labialis may be diminished with daily oral acyclovir or valacyclovir. Topical acyclovir, penciclovir, and docosanol are optional treatments for recurrent herpes labialis, but they are less effective than oral treatment....
Recurrences of herpes labialis may be diminished with daily oral acyclovir or valacyclovir. Topical acyclovir, penciclovir, and docosanol
Topical n-docosanol for management of recurrent herpes labialis.
Treister NS, Woo SB. Treister NS, et al. Expert Opin Pharmacother. 2010 Apr;11(5):853-60. doi: 10.1517/14656561003691847. Expert Opin Pharmacother. 2010. PMID: 20210688 Review.
AREAS COVERED IN THIS REVIEW: The authors conducted a comprehensive search of the published preclinical and clinical literature on topical docosanol for RHL. All of the published literature relating to docosanol and its use for the management of recurrent herpes lab …
AREAS COVERED IN THIS REVIEW: The authors conducted a comprehensive search of the published preclinical and clinical literature on topical …
Inhibition of biofilm and biofilm-associated virulence factor production in methicillin-resistant Staphylococcus aureus by docosanol.
Lakshmi SA, Bhaskar JP, Krishnan V, Sethupathy S, Pandipriya S, Aruni W, Pandian SK. Lakshmi SA, et al. J Biotechnol. 2020 Jun 20;317:59-69. doi: 10.1016/j.jbiotec.2020.04.014. Epub 2020 Apr 28. J Biotechnol. 2020. PMID: 32353392
Results showed that docosanol as a potent antibiofilm agent and found to inhibit several virulence factors of MRSA. The antibiofilm efficacy of docosanol analyzed through light and scanning electron microscopy showed a significant reduction in adherent cells. ...
Results showed that docosanol as a potent antibiofilm agent and found to inhibit several virulence factors of MRSA. The antibiofilm e …
Topical antiviral and antifungal medications in pregnancy: a review of safety profiles.
Patel VM, Schwartz RA, Lambert WC. Patel VM, et al. J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1440-1446. doi: 10.1111/jdv.14297. Epub 2017 Aug 4. J Eur Acad Dermatol Venereol. 2017. PMID: 28449377 Review.
For antiviral medications, acyclovir and trichloroacetic acid are safe to use in pregnancy. Docosanol, imiquimod and penciclovir are likely safe, but should be utilized as second-line agents. ...
For antiviral medications, acyclovir and trichloroacetic acid are safe to use in pregnancy. Docosanol, imiquimod and penciclovir are …
Docosanol: a topical antiviral for herpes labialis.
Leung DT, Sacks SL. Leung DT, et al. Expert Opin Pharmacother. 2004 Dec;5(12):2567-71. doi: 10.1517/14656566.5.12.2567. Expert Opin Pharmacother. 2004. PMID: 15571473 Review.
Over-the-counter treatments are palliative in nature and do not reduce time to healing. Docosanol is a compound with a unique mechanism of action involving viral fusion inhibition. In randomised, clinical trials, a 10% docosanol cream formulation, initiated within 1 …
Over-the-counter treatments are palliative in nature and do not reduce time to healing. Docosanol is a compound with a unique mechani …
Docosanol: new drug. Herpes labialis: barely more effective than an excipient.
[No authors listed] [No authors listed] Prescrire Int. 2009 Jun;18(101):106-7. Prescrire Int. 2009. PMID: 19637417
It reduces healing time by about 2 days provided treatment is started as soon as the first symptoms appear; (2) Docosanol, a fatty alcohol, was recently authorized in France for treatment of episodes of herpes labialis; (3) A trial in 474 patients showed no tangible differ …
It reduces healing time by about 2 days provided treatment is started as soon as the first symptoms appear; (2) Docosanol, a fatty al …
Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
Marcelletti JF. Marcelletti JF. Antiviral Res. 2002 Nov;56(2):153-66. doi: 10.1016/s0166-3542(02)00105-5. Antiviral Res. 2002. PMID: 12367721
Interactions between docosanol (n-docosanol, behenyl alcohol) and nucleoside or pyrophosphate analogs were investigated in vitro. ...An additive anti-HSV effect was observed with docosanol and phosphonoformate (PFA). No evidence was found for either synergist …
Interactions between docosanol (n-docosanol, behenyl alcohol) and nucleoside or pyrophosphate analogs were investigated in vit …
n-Docosanol 10% cream in the treatment of recurrent herpes labialis: a randomised, double-blind, placebo-controlled study.
Habbema L, De Boulle K, Roders GA, Katz DH. Habbema L, et al. Acta Derm Venereol. 1996 Nov;76(6):479-81. doi: 10.2340/0001555576479481. Acta Derm Venereol. 1996. PMID: 8982417 Free article. Clinical Trial.
n-Docosanol has been shown to have antiviral activity. To demonstrate the efficacy of n-docosanol 10% cream in the treatment of recurrent herpes labialis, a randomised, double-blind, parallel group, placebo-controlled study was undertaken in 63 patients. ...The cros …
n-Docosanol has been shown to have antiviral activity. To demonstrate the efficacy of n-docosanol 10% cream in the treatment o …
Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
Sacks SL, Thisted RA, Jones TM, Barbarash RA, Mikolich DJ, Ruoff GE, Jorizzo JL, Gunnill LB, Katz DH, Khalil MH, Morrow PR, Yakatan GJ, Pope LE, Berg JE; Docosanol 10% Cream Study Group. Sacks SL, et al. J Am Acad Dermatol. 2001 Aug;45(2):222-30. doi: 10.1067/mjd.2001.116215. J Am Acad Dermatol. 2001. PMID: 11464183 Clinical Trial.
Although the disease is self-limiting in persons with a healthy immune response, patients seek treatment because of the discomfort and visibility of a recurrent lesion. OBJECTIVE: Our purpose was to determine whether docosanol 10% cream (docosanol) is efficacious co …
Although the disease is self-limiting in persons with a healthy immune response, patients seek treatment because of the discomfort and visib …
47 results